CVS HEALTH CORP (1CVS.MI) Fundamental Analysis & Valuation

BIT:1CVS • US1266501006

Current stock price

67.05 EUR
+0.64 (+0.96%)
Last:

This 1CVS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. 1CVS.MI Profitability Analysis

1.1 Basic Checks

  • 1CVS had positive earnings in the past year.
  • 1CVS had a positive operating cash flow in the past year.
  • In the past 5 years 1CVS has always been profitable.
  • Each year in the past 5 years 1CVS had a positive operating cash flow.
1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • 1CVS has a Return On Assets of 0.70%. This is in the lower half of the industry: 1CVS underperforms 66.67% of its industry peers.
  • 1CVS's Return On Equity of 2.35% is on the low side compared to the rest of the industry. 1CVS is outperformed by 63.64% of its industry peers.
  • 1CVS has a Return On Invested Capital of 4.90%. This is in the lower half of the industry: 1CVS underperforms 60.61% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1CVS is in line with the industry average of 6.44%.
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROIC 4.9%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
1CVS.MI Yearly ROA, ROE, ROIC1CVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • The Profit Margin of 1CVS (0.44%) is worse than 66.67% of its industry peers.
  • 1CVS's Profit Margin has declined in the last couple of years.
  • The Operating Margin of 1CVS (2.58%) is worse than 75.76% of its industry peers.
  • In the last couple of years the Operating Margin of 1CVS has declined.
  • Looking at the Gross Margin, with a value of 13.77%, 1CVS is doing worse than 63.64% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1CVS has declined.
Industry RankSector Rank
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
1CVS.MI Yearly Profit, Operating, Gross Margins1CVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

3

2. 1CVS.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1CVS is destroying value.
  • The number of shares outstanding for 1CVS has been increased compared to 1 year ago.
  • The number of shares outstanding for 1CVS has been reduced compared to 5 years ago.
  • The debt/assets ratio for 1CVS has been reduced compared to a year ago.
1CVS.MI Yearly Shares Outstanding1CVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1CVS.MI Yearly Total Debt VS Total Assets1CVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B 250B

2.2 Solvency

  • 1CVS has an Altman-Z score of 2.32. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1CVS (2.32) is better than 69.70% of its industry peers.
  • The Debt to FCF ratio of 1CVS is 8.27, which is on the high side as it means it would take 1CVS, 8.27 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 8.27, 1CVS is in line with its industry, outperforming 57.58% of the companies in the same industry.
  • A Debt/Equity ratio of 0.80 indicates that 1CVS is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.80, 1CVS perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Altman-Z 2.32
ROIC/WACC0.63
WACC7.75%
1CVS.MI Yearly LT Debt VS Equity VS FCF1CVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • 1CVS has a Current Ratio of 0.84. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.84, 1CVS is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.63 indicates that 1CVS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.63, 1CVS is doing worse than 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.63
1CVS.MI Yearly Current Assets VS Current Liabilites1CVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

5

3. 1CVS.MI Growth Analysis

3.1 Past

  • 1CVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.54%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -2.11% on average over the past years.
  • 1CVS shows a small growth in Revenue. In the last year, the Revenue has grown by 7.85%.
  • The Revenue has been growing by 8.39% on average over the past years. This is quite good.
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.08% on average over the next years. This is quite good.
  • Based on estimates for the next years, 1CVS will show a small growth in Revenue. The Revenue will grow by 4.27% on average per year.
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue Next Year1.49%
Revenue Next 2Y3.12%
Revenue Next 3Y3.88%
Revenue Next 5Y4.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1CVS.MI Yearly Revenue VS Estimates1CVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
1CVS.MI Yearly EPS VS Estimates1CVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

5

4. 1CVS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.40, the valuation of 1CVS can be described as very reasonable.
  • Based on the Price/Earnings ratio, 1CVS is valued cheaper than 84.85% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. 1CVS is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 10.64, which indicates a very decent valuation of 1CVS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1CVS indicates a rather cheap valuation: 1CVS is cheaper than 81.82% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, 1CVS is valued rather cheaply.
Industry RankSector Rank
PE 11.4
Fwd PE 10.64
1CVS.MI Price Earnings VS Forward Price Earnings1CVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1CVS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 12.53
EV/EBITDA N/A
1CVS.MI Per share data1CVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

  • 1CVS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.57
PEG (5Y)N/A
EPS Next 2Y10.96%
EPS Next 3Y11.47%

6

5. 1CVS.MI Dividend Analysis

5.1 Amount

  • 1CVS has a Yearly Dividend Yield of 3.70%. Purely for dividend investing, there may be better candidates out there.
  • 1CVS's Dividend Yield is rather good when compared to the industry average which is at 1.69. 1CVS pays more dividend than 90.91% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, 1CVS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.7%

5.2 History

  • The dividend of 1CVS has a limited annual growth rate of 5.96%.
Dividend Growth(5Y)5.96%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1CVS pays out 192.14% of its income as dividend. This is not a sustainable payout ratio.
  • 1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP192.14%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
1CVS.MI Yearly Income VS Free CF VS Dividend1CVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
1CVS.MI Dividend Payout.1CVS.MI Dividend Payout, showing the Payout Ratio.1CVS.MI Dividend Payout.PayoutRetained Earnings

1CVS.MI Fundamentals: All Metrics, Ratios and Statistics

CVS HEALTH CORP

BIT:1CVS (3/13/2026, 7:00:00 PM)

67.05

+0.64 (+0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners90.76%
Inst Owner ChangeN/A
Ins Owners0.98%
Ins Owner ChangeN/A
Market Cap85.30B
Revenue(TTM)402.07B
Net Income(TTM)1.77B
Analysts79.39
Price Target81.48 (21.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.7%
Yearly Dividend2.32
Dividend Growth(5Y)5.96%
DP192.14%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.24%
Min EPS beat(2)8.8%
Max EPS beat(2)15.69%
EPS beat(4)4
Avg EPS beat(4)19.56%
Min EPS beat(4)8.8%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)7.29%
EPS beat(12)10
Avg EPS beat(12)6.2%
EPS beat(16)14
Avg EPS beat(16)5.76%
Revenue beat(2)2
Avg Revenue beat(2)2.03%
Min Revenue beat(2)1.02%
Max Revenue beat(2)3.04%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.02%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.75%
Revenue beat(12)9
Avg Revenue beat(12)1.31%
Revenue beat(16)13
Avg Revenue beat(16)2.17%
PT rev (1m)0%
PT rev (3m)14.72%
EPS NQ rev (1m)-0.56%
EPS NQ rev (3m)-3.19%
EPS NY rev (1m)0%
EPS NY rev (3m)0.01%
Revenue NQ rev (1m)-1.96%
Revenue NQ rev (3m)-3.01%
Revenue NY rev (1m)-1.1%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE 11.4
Fwd PE 10.64
P/S 0.24
P/FCF 12.53
P/OCF 9.19
P/B 1.3
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.88
EY8.77%
EPS(NY)6.3
Fwd EY9.4%
FCF(TTM)5.35
FCFY7.98%
OCF(TTM)7.29
OCFY10.88%
SpS275.68
BVpS51.57
TBVpS-24.53
PEG (NY)1.57
PEG (5Y)N/A
Graham Number82.6
Profitability
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROCE 6.3%
ROIC 4.9%
ROICexc 5.23%
ROICexgc 18.66%
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
FCFM 1.94%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
ROICexc(3y)5.85%
ROICexc(5y)6.83%
ROICexgc(3y)22.7%
ROICexgc(5y)25.24%
ROCE(3y)7.06%
ROCE(5y)8.13%
ROICexgc growth 3Y-15.72%
ROICexgc growth 5Y-3.91%
ROICexc growth 3Y-15.74%
ROICexc growth 5Y-5.12%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
F-Score6
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.7%
Interest Coverage -3.47
Cash Conversion N/A
Profit Quality 441.57%
Current Ratio 0.84
Quick Ratio 0.63
Altman-Z 2.32
F-Score6
WACC7.75%
ROIC/WACC0.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)0.8%
Profit Quality(3y)234.42%
Profit Quality(5y)242.41%
High Growth Momentum
Growth
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%
Revenue Next Year1.49%
Revenue Next 2Y3.12%
Revenue Next 3Y3.88%
Revenue Next 5Y4.27%
EBIT growth 1Y6.02%
EBIT growth 3Y-13.61%
EBIT growth 5Y-5.55%
EBIT Next Year23.87%
EBIT Next 3Y14.96%
EBIT Next 5YN/A
FCF growth 1Y23.41%
FCF growth 3Y-16.58%
FCF growth 5Y-10.28%
OCF growth 1Y16.82%
OCF growth 3Y-13.04%
OCF growth 5Y-7.68%

CVS HEALTH CORP / 1CVS.MI Fundamental Analysis FAQ

What is the fundamental rating for 1CVS stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1CVS.MI.


What is the valuation status of CVS HEALTH CORP (1CVS.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for CVS HEALTH CORP?

CVS HEALTH CORP (1CVS.MI) has a profitability rating of 2 / 10.


How financially healthy is CVS HEALTH CORP?

The financial health rating of CVS HEALTH CORP (1CVS.MI) is 3 / 10.


Is the dividend of CVS HEALTH CORP sustainable?

The dividend rating of CVS HEALTH CORP (1CVS.MI) is 6 / 10 and the dividend payout ratio is 192.14%.